Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.
about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Estimates of HIV incidence from household-based prevalence surveysChild mortality estimation: methods used to adjust for bias due to AIDS in estimating trends in under-five mortalityReview: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaAge-targeted HIV treatment and primary prevention as a 'ring fence' to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South AfricaThe impact of HIV, an antiretroviral programme and tuberculosis on mortality in South African platinum miners, 1992-2010Using age-specific mortality of HIV infected persons to predict anti-retroviral treatment need: a comparative analysis of data from five African population-based cohort studies.Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA).The Age Pattern of Increases in Mortality Affected by HIV: Bayesian Fit of the Heligman-Pollard Model to Data from the Agincourt HDSS Field Site in Rural Northeast South Africa.Economic returns to investment in AIDS treatment in low and middle income countries.Data Resource Profile: Network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA Network).Segmented polynomials for incidence rate estimation from prevalence data.Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections.When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statisticsEstimating incidence from prevalence in generalised HIV epidemics: methods and validation.A missing piece in the puzzle: HIV in mature adults in sub-Saharan AfricaEstimated HIV trends and program effects in Botswana.Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and ageClinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes.HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan AfricaEstimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods.Mixture models for calibrating the BED for HIV incidence testing.Long-term costs and health impact of continued global fund support for antiretroviral therapyAssociation of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.Modeling the population-level effects of male circumcision as an HIV-preventive measure: a gendered perspective.Using tests for recent infection to estimate incidence: problems and prospects for HIVCoreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.Updates to the spectrum model to estimate key HIV indicators for adults and childrenEstimating HIV incidence from case-report data: method and an application in ColombiaEmbracing different approaches to estimating HIV incidence, prevalence and mortality.Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020.Estimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy.
P2860
Q21034169-EA1D1C71-53B1-4C49-8E1F-35F6D75FA6B7Q24634062-435525B1-39D9-4B2D-9379-EA62BF01103DQ26822985-376DB5D3-DA4B-41FD-9DAC-25EDB804D941Q27022927-89C1049C-ADE3-47D0-8FBB-BFE66C4F4301Q28385587-3E31FA38-1EEF-406D-95C8-0E5A3437B3DCQ28728096-0536496E-B16E-4453-AC66-A189F4FF3427Q30560888-B2657F91-0568-4B53-B16D-45EAEF409981Q30627882-66E713F9-D818-473E-908A-CBDA92856342Q30740176-AA21CC8E-6736-4CD6-9D7F-C98454312FFAQ31036894-616E296E-7B9D-42C7-82A5-E69295D00837Q31057094-A29CFBCA-DF31-4244-82FE-266AB36E68E7Q31133298-7654E8DF-8CB9-49A0-BB6D-4621EDF320C5Q31164541-FA920578-A849-4484-AE63-9E93E3A0187FQ33322515-C372E3A2-A778-4D5C-9537-6F73F3BB0E4DQ33347813-325E38DB-9ADE-43F0-B704-63F4AD8937E3Q33353214-337F2D56-FF0D-443F-987D-974E243BC77BQ33384438-D4F4E7BE-C1AB-4893-8C59-DBEB06353473Q33455728-A686CD0D-03C4-4679-8EB2-E1807A8432A6Q33470290-507DF9D7-F7EC-4DF1-96C7-A86247DE75DEQ33558726-B5102122-F8D3-4B74-8F74-B808AD4BDFDFQ33608640-19AA7BF0-BB7C-467C-85A0-21F1E06D962DQ33631159-0674557A-98C6-4D77-AED5-C2FE3B54563EQ33684749-DC321E86-6B48-4B63-B545-9235084F7FF4Q33742029-FFEF8A46-CCE5-41A8-934F-0D2F7D727585Q33780939-CE78BECF-2C71-439F-B2AB-05F1F7DB5AF3Q33797490-9B654739-A2A0-4856-B11C-DDE5962D575FQ33847669-C2838EF3-E710-4762-9EED-0A0026582E8BQ33924641-51B1112F-AE39-48A4-A034-AE2573984D10Q33952153-6D98A079-8FDE-401D-86F1-7C224E82E729Q33958103-01923074-1F98-431C-8B0F-EA3D84B7B172Q34113561-84712FC1-1A34-4A01-A220-216AFDF312E1Q34119836-ED13001F-A5F3-4C40-A9D4-BA5B1771B8C7Q34269253-40263D19-F6C6-4326-8087-1F03D32EADCAQ34339523-B356F4C7-3367-423B-961B-571C6B41842DQ34571215-617BF47A-BE76-4C7E-A7AA-570AEDA424CDQ34585085-8957B0DD-1A36-4669-A813-EE0DC2069D32Q34585105-3583DAF1-3F03-4915-AC62-D44EF4985510Q34585124-E084AEDD-CA44-4526-A8B5-94EF6D25EBDBQ34712785-7EF8D3A6-1B67-4A0C-99C3-2FFA53E27209Q34735093-3C93CA1D-88B2-4E89-92C8-0B25014F2FFA
P2860
Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Time from HIV seroconversion t ...... active antiretroviral therapy.
@en
type
label
Time from HIV seroconversion t ...... active antiretroviral therapy.
@en
prefLabel
Time from HIV seroconversion t ...... active antiretroviral therapy.
@en
P2093
P2860
P50
P921
P1433
P1476
Time from HIV seroconversion t ...... active antiretroviral therapy.
@en
P2093
Dan Fitzgerald
Judith R Glynn
Kenrad E Nelson
Milly Marston
Ram Rangsin
Sam Biraro
Vinai Suriyanon
Wambura Mwita
P2860
P304
P356
10.1097/01.AIDS.0000299411.75269.E8
P407
P478
21 Suppl 6
P577
2007-11-01T00:00:00Z